Is CardioGenics Holdings Inc halal to invest in?

According to Musaffa's Shariah screening methodology, CardioGenics Holdings Inc (CGNH) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is CardioGenics Holdings Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes CardioGenics Holdings Inc using these criteria to determine its compliance status.

Can Muslims buy shares of CardioGenics Holdings Inc?

Muslim investors may consider investing in CardioGenics Holdings Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is CardioGenics Holdings Inc classified as NOT COVERED?

Musaffa determines the Shariah status of CardioGenics Holdings Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for CardioGenics Holdings Inc updated?

The Shariah compliance status of CardioGenics Holdings Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like CardioGenics Holdings Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of CardioGenics Holdings Inc?

You can check the latest Shariah compliance status of CardioGenics Holdings Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

CardioGenics Holdings Inc. Stock Analysis CGNH

United States Health Care Nano Cap

CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. The company is headquartered in Boca Raton, Florida. The company went IPO on 2004-06-09. The firm has developed the QL Care Analyzer, a point-of-care immuno-analyzer, which is capable of running approximately 200+immunoassay diagnostic tests, such as cardiovascular diagnostic tests. As part of its technology, the Company has also developed a method for silver coating paramagnetic microspheres (a fundamental platform component of immunoassay equipment), which improves instrument sensitivity to light.

Key Statistics of CardioGenics Holdings Inc (CGNH)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$0.00$0.00

Today's Open

$0.00

Volume

17.50K

P/E Ratio (TTM)

52 Week Range

$0.00$0.00

Market Cap

9605.10

Avg. Volume

20.00K

Dividend Yield

Financial Metrics & Statements of CardioGenics Holdings Inc (CGNH)

FAQ's for CardioGenics Holdings Inc (CGNH)

According to Musaffa’s Shariah screening methodology, CardioGenics Holdings Inc (CGNH) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.